COMMUNIQUÉS West-GlobeNewswire

Outlook Therapeutics® to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
22/01/2025
Live webcast on Wednesday, January 29th at 2:00 PM ET ISELIN, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the [...]
Altamira Therapeutics Announces Collaboration on Radiopharmaceutical Targeting Strategies
22/01/2025
Hamilton, Bermuda, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Exploring use of Altamira’s RNA nanoparticles in conjunction with radiopharmaceutical cancer treatment Project collaboration partner will have option to negotiate [...]
Bioxytran Secures $1.6 million SPA to Extinguish Note & Fund Clinical Development
22/01/2025
- Repurchasing all convertible note overhang, and - Funding pre-clinical and clinical trials - Management forfeiting $460,000 in accrued payroll BOSTON, MASSACHUSETTS, Jan. 22, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. ( [...]
NeuroSigma Announces Patent Application Protecting Use of Trigeminal Nerve Stimulation to Include Treatment of Dyslexia and Other Neurodevelopmental Disorders
22/01/2025
LOS ANGELES, Jan. 22, 2025 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. , a Los Angeles-based bioelectronics company commercializing the Monarch external Trigeminal Nerve Stimulation (eTNS) device for treating ADHD , today [...]
NEXGEL Issues Letter to Shareholders and Provides Guidance for 2024 and 2025
22/01/2025
Management expects 2024 fourth quarter revenue of approximately $3.0 million and full year 2024 of approximately $8.6 million, representing growth year-over-year of over 100% for the third consecutive year Management [...]
HTM College Education: AAMI Sets New Standard
22/01/2025
First-ever standard for training biomedical, clinical engineers Arlington, Virginia, Jan. 22, 2025 (GLOBE NEWSWIRE) -- There are relatively few healthcare technology management (HTM) educational programs that align with [...]
Sonnet BioTherapeutics to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
22/01/2025
Live webcast on Wednesday, January 29 th at 2:40 PM ET PRINCETON, NJ, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company [...]
Biodexa Strengthens Management Team - Appointment of Dr Gary A. Shangold as Chief Medical Officer
22/01/2025
January 22, 2025 Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage [...]
AIM ImmunoTech Highlights New Article Finding Links Between COVID-19 and ME/CFS
22/01/2025
Recently published article on study findings underscores links between study participants infected with SARS-CoV-2 and the incidence of ME/CFS The early-onset broad-spectrum antiviral effect of Ampligen has been [...]
Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer™
22/01/2025
Partnership highlights Scorpius’ expertise in supporting innovative therapeutic programs DURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an [...]
Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment
22/01/2025
SARASOTA, FL, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today [...]
Tiny Health Launches Index Predicting Child’s Gut Microbiome Age
22/01/2025
AUSTIN, Texas, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Tiny Health , a leader in at-home gut microbiome testing, today announced the launch of its Gut Maturation Index, an advanced machine learning tool that predicts a child’ [...]
OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC
22/01/2025
WARSAW, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today [...]
Noom Introduces Free AI-Powered Personalized Health Report to Promote Living Better Longer
22/01/2025
New Body Age Prediction and Existing Body Composition Analysis Now Available to Everyone, Including Free Members of Noom NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Noom , the leading digital healthcare company [...]
Spectral AI Provides Update to Investors
22/01/2025
DALLAS, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”) , developer of the AI-driven DeepView ® System, which received Breakthrough Device Designation from the U.S. FDA in [...]
IMMvention Therapeutix Enters Strategic Collaboration with Novo Nordisk to Develop Oral Therapies for Sickle Cell Disease and Other Chronic Diseases
22/01/2025
DURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- IMMvention Therapeutix, Inc ., an early-stage biotechnology company focused on discovering and developing human therapeutics, today announced a strategic collaboration and [...]
DiagnaMed and TerraVent Announce Strategic Collaboration for Next-Generation Clean Hydrogen Production
22/01/2025
TORONTO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a leading provider of innovative technology solutions for the cleantech and life sciences [...]
Cullgen Begins Phase 1 Dosing of its Potential First-in-Class, Oral Pan-TRK Protein Degrader for Acute and Chronic Pain
22/01/2025
Pain marks the second therapeutic area for Cullgen’s lead protein degrader CG001419 SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Cullgen Inc. (“Cullgen”), a privately-held, clinical-stage biopharmaceutical company [...]
Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement
22/01/2025
DUBLIN, Ireland, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that Sev Melkonian has [...]

Pages